Ingrid Beattie, PhD, Esq. is a member in the Intellectual Property Section at Mintz, Levin. Her practice emphasizes patent prosecution in the area of biotechnology, particularly in the fields of molecular biology, immunology, microbiology, cardiovascular medicine, clinical diagnostics, and medical devices, and includes advising clients on issues relating to patent portfolio management and licensing. Prior to joining Mintz Levin, Dr. Beattie was a Technology Transfer Associate at the Dana-Farber Cancer Institute, and then practiced at another prominent Boston law firm.
Dr. Beattie is a Past-President of the Boston Patent Law Association. She has been a frequent speaker at Biotechnology Industry Organization conferences, and is also a member of the Licensing Executives Society and of the Association of University Technology Managers (AUTM). Dr. Beattie is admitted to practice in Massachusetts and before the U.S. Patent and Trademark Office. She received her B.S. in biology from Fairfield University (1979), and her Ph.D. in immunology and microbiology from Emory University School of Medicine (1990). Ingrid was awarded her J.D., cum laude, from Suffolk University Law School (1998).